Major shareholders of Nexwise Intelligence China (301248.SZ) collectively increased their holdings by 504,900 shares.
Jec Group (301248.SZ) announcement: The company's controlling shareholder, one of the actual controllers, and chairman Sun Chao, as well as the cont...
Nexwise Intelligence China (301248.SZ) announced that the company's controlling shareholder, one of the actual controllers, and chairman Sun Chao, as well as the controlling shareholder, one of the actual controllers, director, and president Long Fei, collectively increased their holdings by 504,900 shares, accounting for 0.33% of the company's total share capital.
The company's controlling shareholder, one of the actual controllers, and chairman Sun Chao plan to increase their holdings in the company by no less than RMB 10 million within 6 months from the date of the announcement through methods allowed by the Shenzhen Stock Exchange, including but not limited to centralized bidding and block trading. The company's controlling shareholder, one of the actual controllers, director, and president Long Fei plans to increase his holdings in the company by no less than RMB 5 million within 6 months from the date of the announcement through methods allowed by the Shenzhen Stock Exchange, including but not limited to centralized bidding and block trading.
Related Articles

Shanghai Pharmaceuticals Holding(601607.SH): Nicorandil tablets pass consistency evaluation.

HK Stock Market Move | PC Partner (01263) fell by nearly 6% at the close of trading. The company is planning to delist from the Hong Kong Stock Exchange and change its main listing location to the Singapore Exchange.

Meiwei Biological (688062.SH): 13,590 shares of the company's stock were repurchased for the first time through centralized bidding on September 18th.
Shanghai Pharmaceuticals Holding(601607.SH): Nicorandil tablets pass consistency evaluation.

HK Stock Market Move | PC Partner (01263) fell by nearly 6% at the close of trading. The company is planning to delist from the Hong Kong Stock Exchange and change its main listing location to the Singapore Exchange.

Meiwei Biological (688062.SH): 13,590 shares of the company's stock were repurchased for the first time through centralized bidding on September 18th.
